Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A prospective randomized study

Fertility and Sterility

Volumn 76, Issue 3, 2001, Pages 543-549

  Westergaard, Lars G ^a,b   Erb, Karin ^a   Laursen, Steen B ^a   Rex, Sven ^a   Rasmussen, Per E ^a  

^a Fertility Clinic   (Denmark)

^b Fertility Clinic Trianglen   (Denmark)

Author keywords

Clinical outcome; GnRH a down regulation; hMG; ICSI; IVF; Midfollicular LH; rFSH

Indexed keywords

BUSERELIN; BUSERELIN ACETATE; GONADORELIN AGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRANASAL; ADULT; CELL CULTURE TECHNIQUES; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFANT, NEWBORN; INJECTIONS, SUBCUTANEOUS; MENOTROPINS; OOCYTES; PATIENT SELECTION; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 0034882890     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)01973-2     Document Type: Article

References (27)

1. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer; a meta-analysis of randomized controlled trials
2. Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion
3. Steroids in the follicular fluid and the corpus luteum of the mare
4. Purified urinary follicle stimulating hormone induces different hormone profiles compared to menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity
5. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women
6. Role of LH and FSH in ovarian function
7. The role of LH in ovarian stimulation
8. Re-evaluation of the roles of luteinizing hormone and follicle stimulating hormone in the ovulatory process
9. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle-stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization
10. A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation program
11. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction
12. Human chorionic gonadotrophin in commercial menopausal gonadotropin
13. Serum luteinizing hormone concentrations increase 100-fold in females from 7 years of age to adulthood, as measured by time-resolved immunofluorometric assay
14. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone
15. Blastocyst culture and transfer; analysis of results and parameters affecting outcome in two in vitro fertilization programs
16. Human recombinant follicle stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and oestrogen biosynthesis in a woman with isolated gonadotropin deficiency
17. The role of luteinizing hormone in human follicle development and oocyte fertility; evidence from in-vitro fertilization in a women with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone
18. Results of ovulation induction using human menopausal gonadotropins or purified follicle-stimulating hormone in hypogonadotrophic hypogonadism patients
19. Successful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kalmann's syndrome
20. Recombinant human luteinizing hormone (LH) to support recombinant human follicles stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women; a dose-finding study
21. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization
22. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction
23. Studies on the mechanism(s) of mammalian ovulation
24. Nongenomic effects of 17 beta-estradiol on maturing human oocytes; relationship to oocyte developmental potential
25. Disappearance rates of endogenous luteinizing hormone and chorionic gonadotrophin in man
26. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome